Does the combination of a blood test and Fibroscan improve the non-invasive diagnosis of liver fibrosis?
The synchronous combination of a blood test plus LSE improves the accuracy of the non-invasive diagnosis of liver fibrosis and, consequently, markedly decreases the biopsy requirement in the diagnostic algorithm, notably to <10% in cirrhosis diagnosis.
These data provide preliminary evidence that lipid administered through the enteral route protects against PN-associated hepatic injury in an animal model.